BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26229090)

  • 1. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
    Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
    Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
    Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
    Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
    Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
    Motlló C; Grau J; Juncà J; Ruiz N; Mate JL; Orna E; Navarro JT; Vives S; Sancho JM; Esteban D; Granada I; Feliu E; Ribera JM; Millá F
    Cancer Genet Cytogenet; 2010 Dec; 203(2):328-32. PubMed ID: 21156254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
    Wang HY; Bossler AD; Schaffer A; Tomczak E; DiPatri D; Frank DM; Nowell PC; Bagg A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):45-53. PubMed ID: 17175379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
    Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
    Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long distance polymerase chain reaction for detection of chromosome translocations in B-cell lymphoma/leukemia.
    Akasaka T; Ohno H; Mori T; Okuma M
    Leukemia; 1997 Apr; 11 Suppl 3():316-7. PubMed ID: 9209376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
    Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptic t(3;8)(q27;q24) and/or MYC-BCL6 linkage associated with MYC expression by immunohistochemistry is frequent in multiple-hit B-cell lymphomas.
    Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Honjo G
    Blood Cancer J; 2017 Jun; 7(6):e578. PubMed ID: 28665415
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective Enhancer Dependencies in
    Iyer AR; Gurumurthy A; Kodgule R; Aguilar AR; Saari T; Ramzan A; Rausch D; Gupta J; Hall CN; Runge JS; Weiss M; Rahmat M; Anyoha R; Fulco CP; Ghobrial IM; Engreitz J; Cieslik MP; Ryan RJH
    bioRxiv; 2023 May; ():. PubMed ID: 37205448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non-Hodgkin lymphoma.
    Keller CE; Nandula S; Vakiani E; Alobeid B; Murty VV; Bhagat G
    Hum Pathol; 2006 Aug; 37(8):1093-9. PubMed ID: 16867873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
    Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
    Koduru PR; Chen W; Garcia R; Fuda F
    Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.